Surveying the Impact of COVID-19 on Epilepsy Care
People with epilepsy (PWE) are particularly vulnerable to the changes in healthcare delivery that...
Read MoreOct 19, 2020
People with epilepsy (PWE) are particularly vulnerable to the changes in healthcare delivery that...
Read MoreOct 13, 2020
Previous research has shown that women with early-stage cervical cancer who undergo radical...
Read MoreOct 12, 2020
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreOct 12, 2020
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreOct 12, 2020
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreOct 12, 2020
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreOct 12, 2020
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreOct 9, 2020
When treating patients with acne, obtaining an accurate medication history is recommended to...
Read MoreOct 8, 2020
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Records for COVID-19 hospitalizations were set...
Read MoreOct 5, 2020
Hypertension is a major global public health concern and continues to be the leading cause of...
Read MoreOct 5, 2020
Agency responds to reports of severe reactions in participants in viral TikTok trend WASHINGTON...
Read MoreOct 2, 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Introduction of gluten from age 4 months is...
Read MoreOct 1, 2020
THURSDAY, Oct. 1 2020 (HealthDay News) — Children who have bronchitis at least once before...
Read MoreOct 1, 2020
The dual nature of pancreatic tissue permits both endocrine and exocrine functions. Enzymatic...
Read MoreOct 1, 2020
Macrophages are the most abundant immune cells in the microenvironment of solid tumors. The...
Read MoreSep 30, 2020
Although many patients are aware of the risks associated with influenza, they may still be...
Read MoreSep 25, 2020
“Most patients with hepatitis B virus (HBV) infection do not know that they currently have or have...
Read MoreSep 24, 2020
Lorlatinib is a third generation ALK tyrosine kinase inhibitor. The phase 3 CROWN study shows...
Read MoreSep 24, 2020
Most patients with metastatic urothelial cancer respond to first-line chemotherapy but relapse...
Read MoreSep 24, 2020
Both CheckMate-649 and ATTRACTION-4 showed a statistically significant improvement in...
Read More